Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian populations

Cancer is a leading cause of death worldwide. The cancer incidence rate in Chile is 133.7/100,000 inhabitants and it is the second cause of death, after cardiovascular diseases. Most of the antineoplastic drugs are metabolized to be detoxified, and some of them to be activated. Genetic polymorphisms...

Full description

Bibliographic Details
Main Authors: Angela Margarita Roco, Luis Abel Quiñones, José A G Agúndez, Elena eGarcía-Martín, Valentina eSquicciarini, Carla Estefania Miranda, Joselyn eGaray, Nancy eFarfán, Iván Nicolás Saavedra, Dante Daniel Caceres, Carol eIbarra, Nelson Miguel Varela
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-11-01
Series:Frontiers in Genetics
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fgene.2012.00229/full
_version_ 1819142776288182272
author Angela Margarita Roco
Angela Margarita Roco
Angela Margarita Roco
Luis Abel Quiñones
José A G Agúndez
Elena eGarcía-Martín
Valentina eSquicciarini
Carla Estefania Miranda
Joselyn eGaray
Nancy eFarfán
Iván Nicolás Saavedra
Dante Daniel Caceres
Carol eIbarra
Carol eIbarra
Nelson Miguel Varela
Nelson Miguel Varela
author_facet Angela Margarita Roco
Angela Margarita Roco
Angela Margarita Roco
Luis Abel Quiñones
José A G Agúndez
Elena eGarcía-Martín
Valentina eSquicciarini
Carla Estefania Miranda
Joselyn eGaray
Nancy eFarfán
Iván Nicolás Saavedra
Dante Daniel Caceres
Carol eIbarra
Carol eIbarra
Nelson Miguel Varela
Nelson Miguel Varela
author_sort Angela Margarita Roco
collection DOAJ
description Cancer is a leading cause of death worldwide. The cancer incidence rate in Chile is 133.7/100,000 inhabitants and it is the second cause of death, after cardiovascular diseases. Most of the antineoplastic drugs are metabolized to be detoxified, and some of them to be activated. Genetic polymorphisms of drug-metabolizing enzymes can induce deep changes in enzyme activity, leading to individual variability in drug efficacy and/or toxicity. The present research describes the presence of genetic polymorphisms in the Chilean population, which might be useful in public health programs for personalized treatment of cancer, and compare these frequencies with those reported for Asian and Caucasian populations, as a contribution to the evaluation of ethnic differences in the response to chemotherapy.We analyzed 23 polymorphisms in a group of 253 unrelated Chilean volunteers from the general population. The results showed that CYP2A6*2, CYP2A6*3, CYP2D6*3, CYP2C19*3 and CYP3A4*17 variant alleles are virtually absent in Chileans. CYP1A1*2A allele frequency (0.37) is similar to that of Caucasians and higher than that reported for Japanese people. Allele frequencies for CYP3A5*3 (0.76) and CYP2C9*3 (0.04) are similar to those observed in Japanese people. CYP1A1*2C (0.32), CYP1A2*1F (0.77), CYP3A4*1B(0.06), CYP2D6*2(0.41) and MTHFR T(0.52) allele frequencies are higher than the observed either in Caucasian or in Japanese populations. Conversely, CYP2C19*2 allele frequency (0.12) and GSTT1null (0.11) and GSTM1null (0.36) genotype frequencies are lower than those observed in both populations. Finally, allele frequencies for CYP2A6*4(0.04), CYP2C8*3(0.06), CYP2C9*2(0.06), CYP2D6*4(0.12), CYP2E1*5B(0.14), CYP2E1*6(0.19), and UGT2B7*2(0.40) are intermediate in relation to those described in Caucasian and in Japanese populations, as expected according to the ethnic origin of the Chilean population.In conclusion, our findings support the idea that ethnic variability must be considered
first_indexed 2024-12-22T12:15:43Z
format Article
id doaj.art-b109014d66f44d5f8560f6dd3656da52
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-22T12:15:43Z
publishDate 2012-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-b109014d66f44d5f8560f6dd3656da522022-12-21T18:26:09ZengFrontiers Media S.A.Frontiers in Genetics1664-80212012-11-01310.3389/fgene.2012.0022935225Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian populationsAngela Margarita Roco0Angela Margarita Roco1Angela Margarita Roco2Luis Abel Quiñones3José A G Agúndez4Elena eGarcía-Martín5Valentina eSquicciarini6Carla Estefania Miranda7Joselyn eGaray8Nancy eFarfán9Iván Nicolás Saavedra10Dante Daniel Caceres11Carol eIbarra12Carol eIbarra13Nelson Miguel Varela14Nelson Miguel Varela15Faculty of Medicine, University of ChileAndrés Bello UniversitySan Juan de Dios HospitalFaculty of Medicine, University of ChileUniversity of ExtremaduraUniversity of ExtremaduraFaculty of Medicine, University of ChileFaculty of Medicine, University of ChileFaculty of Medicine, University of ChileFaculty of Medicine, University of ChileFaculty of Medicine, University of ChileUniversity of ChileFaculty of Medicine, University of ChileSanto Tomás UniversityFaculty of Medicine, University of ChileFaculty of Medicine, University of ChileCancer is a leading cause of death worldwide. The cancer incidence rate in Chile is 133.7/100,000 inhabitants and it is the second cause of death, after cardiovascular diseases. Most of the antineoplastic drugs are metabolized to be detoxified, and some of them to be activated. Genetic polymorphisms of drug-metabolizing enzymes can induce deep changes in enzyme activity, leading to individual variability in drug efficacy and/or toxicity. The present research describes the presence of genetic polymorphisms in the Chilean population, which might be useful in public health programs for personalized treatment of cancer, and compare these frequencies with those reported for Asian and Caucasian populations, as a contribution to the evaluation of ethnic differences in the response to chemotherapy.We analyzed 23 polymorphisms in a group of 253 unrelated Chilean volunteers from the general population. The results showed that CYP2A6*2, CYP2A6*3, CYP2D6*3, CYP2C19*3 and CYP3A4*17 variant alleles are virtually absent in Chileans. CYP1A1*2A allele frequency (0.37) is similar to that of Caucasians and higher than that reported for Japanese people. Allele frequencies for CYP3A5*3 (0.76) and CYP2C9*3 (0.04) are similar to those observed in Japanese people. CYP1A1*2C (0.32), CYP1A2*1F (0.77), CYP3A4*1B(0.06), CYP2D6*2(0.41) and MTHFR T(0.52) allele frequencies are higher than the observed either in Caucasian or in Japanese populations. Conversely, CYP2C19*2 allele frequency (0.12) and GSTT1null (0.11) and GSTM1null (0.36) genotype frequencies are lower than those observed in both populations. Finally, allele frequencies for CYP2A6*4(0.04), CYP2C8*3(0.06), CYP2C9*2(0.06), CYP2D6*4(0.12), CYP2E1*5B(0.14), CYP2E1*6(0.19), and UGT2B7*2(0.40) are intermediate in relation to those described in Caucasian and in Japanese populations, as expected according to the ethnic origin of the Chilean population.In conclusion, our findings support the idea that ethnic variability must be consideredhttp://journal.frontiersin.org/Journal/10.3389/fgene.2012.00229/fullbiomarkerspolymorphismsMTHFRPharmacogenetics and pharmacogenomicsCYP450Antineoplastic
spellingShingle Angela Margarita Roco
Angela Margarita Roco
Angela Margarita Roco
Luis Abel Quiñones
José A G Agúndez
Elena eGarcía-Martín
Valentina eSquicciarini
Carla Estefania Miranda
Joselyn eGaray
Nancy eFarfán
Iván Nicolás Saavedra
Dante Daniel Caceres
Carol eIbarra
Carol eIbarra
Nelson Miguel Varela
Nelson Miguel Varela
Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian populations
Frontiers in Genetics
biomarkers
polymorphisms
MTHFR
Pharmacogenetics and pharmacogenomics
CYP450
Antineoplastic
title Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian populations
title_full Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian populations
title_fullStr Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian populations
title_full_unstemmed Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian populations
title_short Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian populations
title_sort frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population comparison with caucasian and asian populations
topic biomarkers
polymorphisms
MTHFR
Pharmacogenetics and pharmacogenomics
CYP450
Antineoplastic
url http://journal.frontiersin.org/Journal/10.3389/fgene.2012.00229/full
work_keys_str_mv AT angelamargaritaroco frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT angelamargaritaroco frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT angelamargaritaroco frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT luisabelquinones frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT joseagagundez frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT elenaegarciamartin frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT valentinaesquicciarini frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT carlaestefaniamiranda frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT joselynegaray frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT nancyefarfan frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT ivannicolassaavedra frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT dantedanielcaceres frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT caroleibarra frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT caroleibarra frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT nelsonmiguelvarela frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations
AT nelsonmiguelvarela frequenciesof23functionallysignificantvariantallelesrelatedwithmetabolismofantineoplasticdrugsinthechileanpopulationcomparisonwithcaucasianandasianpopulations